Evotec expanding at Milton Park campus

According to Evotec, adding a new building by the end of the year, will bring together all the key functions for small molecule discovery and up to commercial development. The campus will boast the co-location of in vitro pharmacology and protein sciences, structural biology, drug metabolism and pharmacokinetics, computational, synthetic, and medicinal chemistry, formulation sciences, development chemistry and API manufacture. By co-locating these critical scientific functions, Evotec aims to improve communication and problem-solving at the interfaces of disciplines as well as accelerating the speed of iterative cycles in the drug discovery and development processes.

Evotec’s campus at Milton Park already benefits from the relationships and proximity with the Diamond Light Source at Harwell, as well as partnership opportunities in the UK-wide biotech scene. With over 600 employees on site, the Dorothy Crowfoot Hodgkin Campus now joins Evotec’s sites in Toulouse and Verona as one of three fully integrated powerhouses of capacity, capabilities and know-how in integrated R&D.